{"title":"Association between miR-27a rs895819 polymorphism and antidepressant treatment response in patients with depression.","authors":"Yanle Bai, Junjuan Zhu, Chunhu Zhang, Kuancai Deng, Yingzhi Xu","doi":"10.1159/000546405","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Depression is a prevalent mental health disorder. miR-27a regulates neuronal development. This study aimed to investigate the association between the miR-27a rs895819 polymorphism and antidepressant treatment response in patients with depression.</p><p><strong>Methods: </strong>The expression level of miR-27a was detected by reverse transcription-polymerase chain reaction. The genotype of rs895819 was performed by PCR-restriction fragment length polymorphism. The condition of patients was evaluated by a 17-item Hamilton Depression Rating Scale (HAMD-17). Reduction rate = (HAMD-17 baseline- HAMD-17 8 week)/ HAMD-17 baseline × 100%. Effective response was defined as a reduction rate of ≥50%. Remission was defined as HAMD-17 ≤17. The association between SNP and depression risk was calculated by the χ2 test. Logistic regression analysis was performed to evaluate the effects of SNP on antidepressant treatment response.</p><p><strong>Results: </strong>There were 173 patients with depression and 186 healthy controls. rs895819 was negatively correlated with depression under CC vs. TT (P=0.044, OR=0.412, 95%CI=0.170-0.996), CC+TC vs. TT (OR=0.607, 95%CI=0.397-0.927) and C vs. T (OR=0.633, 95%CI=0.448-0.896) models. miR-27a expression was significantly decreased in individuals with TC/CC genotypes than TT genotypes. rs895819 (TC/CC) was positively correlated with the effective response (P=0.005, OR=2.551, 95%CI=1.322-4.920).</p><p><strong>Conclusion: </strong>rs895819 TC/CC genotypes were significantly correlated with depression, and associated with increased effective response.</p>","PeriodicalId":19239,"journal":{"name":"Neuropsychobiology","volume":" ","pages":"1-16"},"PeriodicalIF":2.3000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropsychobiology","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1159/000546405","RegionNum":4,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Depression is a prevalent mental health disorder. miR-27a regulates neuronal development. This study aimed to investigate the association between the miR-27a rs895819 polymorphism and antidepressant treatment response in patients with depression.
Methods: The expression level of miR-27a was detected by reverse transcription-polymerase chain reaction. The genotype of rs895819 was performed by PCR-restriction fragment length polymorphism. The condition of patients was evaluated by a 17-item Hamilton Depression Rating Scale (HAMD-17). Reduction rate = (HAMD-17 baseline- HAMD-17 8 week)/ HAMD-17 baseline × 100%. Effective response was defined as a reduction rate of ≥50%. Remission was defined as HAMD-17 ≤17. The association between SNP and depression risk was calculated by the χ2 test. Logistic regression analysis was performed to evaluate the effects of SNP on antidepressant treatment response.
Results: There were 173 patients with depression and 186 healthy controls. rs895819 was negatively correlated with depression under CC vs. TT (P=0.044, OR=0.412, 95%CI=0.170-0.996), CC+TC vs. TT (OR=0.607, 95%CI=0.397-0.927) and C vs. T (OR=0.633, 95%CI=0.448-0.896) models. miR-27a expression was significantly decreased in individuals with TC/CC genotypes than TT genotypes. rs895819 (TC/CC) was positively correlated with the effective response (P=0.005, OR=2.551, 95%CI=1.322-4.920).
Conclusion: rs895819 TC/CC genotypes were significantly correlated with depression, and associated with increased effective response.
期刊介绍:
The biological approach to mental disorders continues to yield innovative findings of clinical importance, particularly if methodologies are combined. This journal collects high quality empirical studies from various experimental and clinical approaches in the fields of Biological Psychiatry, Biological Psychology and Neuropsychology. It features original, clinical and basic research in the fields of neurophysiology and functional imaging, neuropharmacology and neurochemistry, neuroendocrinology and neuroimmunology, genetics and their relationships with normal psychology and psychopathology. In addition, the reader will find studies on animal models of mental disorders and therapeutic interventions, and pharmacoelectroencephalographic studies. Regular reviews report new methodologic approaches, and selected case reports provide hints for future research. ''Neuropsychobiology'' is a complete record of strategies and methodologies employed to study the biological basis of mental functions including their interactions with psychological and social factors.